Search results
Results from the WOW.Com Content Network
Shares of AstraZeneca finished last week just a few dollars away from the stock's 52-week low of $60.47. The stock has been struggling despite a strong quarterly report this month.
In today's video, I am going to cover four growth stocks trading near their 52-week lows. Watch the short video to learn more, consider subscribing, and click the special offer link below. *Stock ...
Rounding out this list of discounted stocks is drugmaker Merck, which is just a few dollars away from its 52-week low of $98.60. It hasn't experienced a steep sell-off this year, but its 6% ...
When it comes to investing, just because a company is trading at a 52-week low, that does not necessarily mean it is a buy. The same goes for a stock at a 52-week high not necessarily being a sell.
Meanwhile, PepsiCo (NASDAQ: PEP) is having a terrible year, falling 6.6% YTD to around a three-year low. Here's why both blue chip stocks could be worth buying now, but for entirely different reasons.
At about $69 per share, DexCom's stock isn't that far off its 52-week low of $62.34 and is miles away from its 52-week high of $142. However, there remain good reasons to invest in the company ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
These stocks near 52-week lows could be ready to rebound. ... The S&P 500 index is up 20% year to date with several high-profile companies delivering spectacular returns heading into 2025. At the ...